FDA.reportPublic FDA data

tiZANidine 2 MG in 5 mL Oral Solution

RxCUI
2709432
RxNorm name
tiZANidine 2 MG in 5 mL Oral Solution
Display name
tiZANidine 2 MG in 5 mL Oral Solution
Full name
tiZANidine 2 MG in 5 mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OntralfyTIZANIDINE HYDROCHLORIDERosemont Pharmaceuticals, LLC7b88c338-c0b7-4c08-bef6-a4ffc2f25df72025-10-25Warnings, Adverse reactionsExact identifier
rxcui: 2709432

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7b88c338-c0b7-4c08-bef6-a4ffc2f25df7tiZANidine 2 MG in 5 mL Oral Solution [PSN] · tizanidine 0.4 MG/ML Oral Solution [SCD] · tizanidine 2 MG per 5 mL (as tizanidine hydrochloride 2.29 MG per 5 mL) Oral Solution [SY]32These highlights do not include all the information needed to use ONTRALFY™ safely and effectively. See full prescribing information for ONTRALFY. ONTRALFY™ (tizanidine oral solution) Initial U.S. Approval: 199620251025